HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bérengère Cador Selected Research

Sirolimus (Rapamycin)

1/2020Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bérengère Cador Research Topics

Disease

1Fatigue
07/2020
1Gaucher Disease (Gaucher's Disease)
02/2020
1Paraproteinemias (Monoclonal Gammopathy)
02/2020
1Eosinophilic Fasciitis
01/2020
1Infections
09/2002
1Diarrhea
09/2002

Drug/Important Bio-Agent (IBA)

1Hemoglobins (Hemoglobin)IBA
07/2020
1chitotriosidaseIBA
07/2020
1Glucosylceramidase (Glucocerebrosidase)IBA
02/2020
1Immunoglobulins (Immunoglobulin)IBA
02/2020
1Sirolimus (Rapamycin)FDA Link
01/2020
1NivolumabIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
09/2002